Neural control of blood flow during exercise in human metabolic syndrome

Experimental Physiology

Volumn 99, Issue 9, 2014, Pages 1191-1202

  Limberg, Jacqueline K ^a   Morgan, Barbara J ^b   Sebranek, Joshua J ^b   Proctor, Lester T ^b   Eldridge, Marlowe W ^b   Schrage, William G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; HIGH DENSITY LIPOPROTEIN; LEPTIN; PHENTOLAMINE; PHENYLEPHRINE; PROPRANOLOL; TRIACYLGLYCEROL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC ACTIVITY; ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD FLOW; BLOOD FLOWMETRY; BLOOD VESSEL REACTIVITY; BODY FAT; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DYNAMIC EXERCISE; EXERCISE; FEMALE; FOREARM BLOOD FLOW; HEART OUTPUT; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MUSCLE CONTRACTION; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRESSOR RESPONSE; STATISTICAL SIGNIFICANCE; VASOCONSTRICTION; VASODILATATION; WAIST CIRCUMFERENCE; ADAPTATION; ADRENERGIC SYSTEM; ARM; BLOOD FLOW VELOCITY; CASE CONTROL STUDY; DRUG EFFECTS; HAND STRENGTH; INNERVATION; INTRAARTERIAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; TIME; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; EXERCISE; FEMALE; HAND STRENGTH; HUMANS; INFUSIONS, INTRA-ARTERIAL; LASER-DOPPLER FLOWMETRY; MALE; METABOLIC SYNDROME X; MUSCLE CONTRACTION; MUSCLE, SKELETAL; REGIONAL BLOOD FLOW; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; UPPER EXTREMITY; VASOCONSTRICTION; VASODILATION;

EID: 84908342829     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.078048     Document Type: Article

References (48)

1. Agapitov AV, Correia ML, Sinkey CA & Haynes WG (2008). Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 52, 687-695.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM & Smith SC Jr (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
3. Ardévol A, Adán C, Remesar X, Alemany M & Fernández-López JA (1996). Muscle blood flow during intense exercise in the obese rat. Arch Physiol Biochem 104, 337-343.
4. Beltowski J (2012). Leptin and the regulation of endothelial function in physiological and pathological conditions. Clin Exp Pharmacol Physiol 39, 168-178.
5. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC & Stinson EB (1982). Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307, 205-211.
6. Casey DP, Madery BD, Pike TL, Eisenach JH, Dietz NM, Joyner MJ & Wilkins BW (2009). Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise. J Appl Physiol 107, 1128-1137.
7. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB & Wallin BG (2006). Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572, 821-827.
8. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, Hudgel D, Sateia M & Schwab R (2007). Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 3, 737-747.
9. Deniz F, Katircibasi MT, Pamukcu B, Binici S & Sanisoglu SY (2007). Association of metabolic syndrome with impaired heart rate recovery and low exercise capacity in young male adults. Clin Endocrinol (Oxf) 66, 218-223.
10. Dincer ÜD, Araiza AG, Knudson JD, Molina PE & Tune JD (2006). Sensitization of coronary α-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation 13, 587-595.
11. Dinenno FA, Dietz NM & Joyner MJ (2002). Aging and forearm postjunctional α-adrenergic vasoconstriction in healthy men. Circulation 106, 1349-1354.
12. Dinenno FA & Joyner MJ (2006). α-Adrenergic control of skeletal muscle circulation at rest and during exercise in aging humans. Microcirculation 13, 329-341.
13. Dinenno FA, Masuki S & Joyner MJ (2005). Impaired modulation of sympathetic α-adrenergic vasoconstriction in contracting forearm muscle of ageing men. J Physiol 567, 311-321.
14. Dinenno FA, Tanaka H, Stauffer BL & Seals DR (2001). Reductions in basal limb blood flow and vascular conductance with human ageing: role for augmented α-adrenergic vasoconstriction. J Physiol 536, 977-983.
15. Eklund B & Kaijser L (1976). Effect of regional α- and β-adrenergic blockade on blood flow in the resting forearm during contralateral isometric handgrip. J Physiol 262, 39-50.
16. Ellis CG, Goldman D, Hanson M, Stephenson AH, Milkovich S, Benlamri A, Ellsworth ML & Sprague RS (2010). Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. Am J Physiol Heart Circ Physiol 298, H1661-H1670.
17. Frisbee JC (2003). Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285, R1124-R1134.
18. Frisbee JC (2004). Enhanced arteriolar α-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97, 764-772.
19. Frisbee JC (2006). Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats. Am J Physiol Heart Circ Physiol 290, H2066-H2074.
20. Frisbee JC, Goodwill AG, Butcher JT & Olfert IM (2011a). Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome. Exp Physiol 96, 369-383.
21. Frisbee JC, Wu F, Goodwill AG, Butcher JT & Beard DA (2011b). Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 301, R975-R986.
22. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr & Lenfant C (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438.
23. Hogikyan RV & Supiano MA (1994). Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol Endocrinol Metab 266, E717-E724.
24. Huggett RJ, Burns J, Mackintosh AF & Mary DASG (2004). Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44, 847-852.
25. Kirby BS, Voyles WF, Carlson RE & Dinenno FA (2008). Graded sympatholytic effect of exogenous ATP on postjunctional α-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle. J Physiol 586, 4305-4316.
26. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E & Lambert G (2007). Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 50, 862-868.
27. Limberg JK, Eldridge MW, Proctor LT, Sebranek JJ & Schrage WG (2010b). α-Adrenergic control of blood flow during exercise: effect of sex and menstrual phase. J Appl Physiol 109, 1360-1368.
28. Limberg JK, Evans TD, Blain GM, Pegelow DF, Danielson JR, Eldridge MW, Proctor LT, Sebranek JJ & Schrage WG (2012a). Effect of obesity and metabolic syndrome on hypoxic vasodilation. Eur J Appl Physiol 112, 699-709.
29. Limberg JK, Morgan BJ, Sebranek JJ, Proctor LT, Walker BJ, Eldridge MW & Schrage WG (2012b). Altered neurovascular control of the resting circulation in human metabolic syndrome. J Physiol 590, 6109-6119.
30. Markwald RR, Kirby BS, Crecelius AR, Carlson RE, Voyles WF & Dinenno FA (2011). Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans. J Physiol 589, 1979-1990.
31. 2-adrenergic properties of dexmedetomidine over clonidine in the human forearm. J Appl Physiol 99, 587-592.
32. Paffenbarger RS Jr, Blair SN, Lee IM & Hyde RT (1993). Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25, 60-70.
33. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547, 971-976.
34. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP & Esler MD (1999). Neural mechanisms in human obesity-related hypertension. J Hypertens 17, 1125-1133.
35. Scherrer U & Sartori C (1997). Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96, 4104-4113.
36. Senechal M, Bouchard DR, Dionne IJ & Brochu M (2012). Lifestyle habits and physical capacity in patients with moderate or severe metabolic syndrome. Metab Syndr Relat Disord 10, 232-240.
37. Smith MM & Minson CT (2012). Obesity and adipokines: effects on sympathetic overactivity. J Physiol 590, 1787-1801.
38. Stepp DW & Frisbee JC (2002). Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282, H816-H820.
39. Thomas GD & Segal SS (2004). Neural control of muscle blood flow during exercise. J Appl Physiol 97, 731-738.
40. Tsioufis C, Kasiakogias A, Tsiachris D, Kordalis A, Thomopoulos C, Giakoumis M, Bounas P, Pittaras A, Michaelides A & Stefanadis C (2012). Metabolic syndrome and exaggerated blood pressure response to exercise in newly diagnosed hypertensive patients. Eur J Prev Cardiol 19, 467-473.
41. Victor RG, Seals DR & Mark AL (1987). Differential control of heart rate and sympathetic nerve activity during dynamic exercise. Insight from intraneural recordings in humans. J Clin Invest 79, 508-516.
42. Vongpatanasin W, Wang Z, Arbique D, Arbique G, Adams-Huet B, Mitchell JH, Victor RG & Thomas GD (2011). Functional sympatholysis is impaired in hypertensive humans. J Physiol 589, 1209-1220.
43. Wallin BG & Charkoudian N (2007). Sympathetic neural control of integrated cardiovascular function: insights from measurement of human sympathetic nerve activity. Muscle Nerve 36, 595-614.
44. West DB, Prinz WA, Francendese AA & Greenwood MR (1987). Adipocyte blood flow is decreased in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 253, R228-R233.
45. Wijndaele K, Duvigneaud N, Matton L, Duquet W, Thomis M, Beunen G, Lefevre J & Philippaerts RM (2007). Muscular strength, aerobic fitness, and metabolic syndrome risk in Flemish adults. Med Sci Sports Exerc 39, 233-240.
46. Wilkins BW, Pike TL, Martin EA, Curry TB, Ceridon ML & Joyner MJ (2008). Exercise intensity-dependent contribution of β-adrenergic receptor-mediated vasodilatation in hypoxic humans. J Physiol 586, 1195-1205.
47. 1-adrenergic vasoconstriction in the regulation of skeletal muscle blood flow with advancing age. Am J Physiol Heart Circ Physiol 296, H497-H504.
48. Wu F, Beard DA & Frisbee JC (2011). Computational analyses of intravascular tracer washout reveal altered capillary-level flow distributions in obese Zucker rats. J Physiol 589, 4527-4543.